Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M23,178Revenue (TTM) $M9,938Net Margin (%)8.1Altman Z-Score1.9
Enterprise Value $M30,301EPS (TTM) $1.6Operating Margin %15.5Piotroski F-Score5
P/E(ttm)27.6Beneish M-Score-2.7Pre-tax Margin (%)9.0Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %13.1Quick Ratio2.7Cash flow > EarningsY
Price/Sales2.25-y EBITDA Growth Rate %7.5Current Ratio3.2Lower Leverage y-yN
Price/Free Cash Flow18.7y-y EBITDA Growth Rate %2.9ROA % (ttm)3.4Higher Current Ratio y-yY
Dividend Yield %--PEG4.1ROE % (ttm)8.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M535ROIC % (ttm)8.2Gross Margin Increase y-yN

Gurus Latest Trades with MYL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYLDavid Einhorn 2016-06-30 Add1.63%$38.62 - $48.8
($44.27)
$ 42.85-3%Add 71.11%4,945,000
MYLJohn Paulson 2016-06-30 Reduce-0.46%$38.62 - $48.8
($44.27)
$ 42.85-3%Reduce -5.60%22,028,061
MYLJoel Greenblatt 2016-06-30 Sold Out -0.44%$38.62 - $48.8
($44.27)
$ 42.85-3%Sold Out0
MYLVanguard Health Care Fund 2016-06-30 Add0.12%$38.62 - $48.8
($44.27)
$ 42.85-3%Add 4.82%27,965,385
MYLMario Gabelli 2016-06-30 Reduce$38.62 - $48.8
($44.27)
$ 42.85-3%Reduce -17.65%14,000
MYLDavid Tepper 2016-03-31 Sold Out -0.92%$41.42 - $54.09
($48.28)
$ 42.85-11%Sold Out0
MYLJoel Greenblatt 2016-03-31 Add0.44%$41.42 - $54.09
($48.28)
$ 42.85-11%Add 9178.19%837,728
MYLVanguard Health Care Fund 2016-03-31 Add0.25%$41.42 - $54.09
($48.28)
$ 42.85-11%Add 10.00%26,679,385
MYLJohn Paulson 2016-03-31 Add0.19%$41.42 - $54.09
($48.28)
$ 42.85-11%Add 2.38%23,335,861
MYLKeeley Asset Management Corp 2016-03-31 Sold Out -0.09%$41.42 - $54.09
($48.28)
$ 42.85-11%Sold Out0
MYLMario Gabelli 2016-03-31 Reduce$41.42 - $54.09
($48.28)
$ 42.85-11%Reduce -35.73%17,000
MYLDavid Einhorn 2015-12-31 Buy 2.86%$39.16 - $55.28
($48.35)
$ 42.85-11%New holding2,890,000
MYLDavid Tepper 2015-12-31 Add0.41%$39.16 - $55.28
($48.35)
$ 42.85-11%Add 81.62%853,749
MYLJohn Paulson 2015-12-31 Add0.29%$39.16 - $55.28
($48.35)
$ 42.85-11%Add 4.02%22,794,061
MYLVanguard Health Care Fund 2015-12-31 Add0.11%$39.16 - $55.28
($48.35)
$ 42.85-11%Add 4.26%24,253,075
MYLJoel Greenblatt 2015-12-31 Buy 0.01%$39.16 - $55.28
($48.35)
$ 42.85-11%New holding9,029
MYLMario Gabelli 2015-12-31 Reduce-0.01%$39.16 - $55.28
($48.35)
$ 42.85-11%Reduce -60.67%26,450
MYLKeeley Asset Management Corp 2015-12-31 Reduce$39.16 - $55.28
($48.35)
$ 42.85-11%Reduce -8.09%51,580
MYLDavid Tepper 2015-09-30 Reduce-0.87%$39.8 - $71.49
($55.75)
$ 42.85-23%Reduce -52.50%470,071
MYLVanguard Health Care Fund 2015-09-30 Add0.64%$39.8 - $71.49
($55.75)
$ 42.85-23%Add 46.38%23,262,875
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MYL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BRESCH HEATHER MCEO 2016-08-09Sell100,200$50-14.3view
MAROON JOSEPH C MDDirector 2016-06-03Buy1,670$44.95-4.67view
MAROON JOSEPH C MDDirector 2016-05-25Buy2,370$42.470.89view
Cindrich Robert JDirector 2016-05-25Buy1,190$42.470.89view
HIGGINS MELINA EDirector 2016-05-12Buy19,900$38.6810.78view
HIGGINS MELINA EDirector 2016-05-06Buy100$38.6910.75view
HIGGINS MELINA EDirector 2016-04-28Buy35,000$42.92-0.16view
COURY ROBERT JExecutive Chairman 2016-04-05Sell217,755$45.96-6.77view
MAROON JOSEPH C MDDirector 2016-03-31Buy4,337$46.36-7.57view
PARRISH MARK WDirector 2016-03-17Buy1,705$44-2.61view

Press Releases about MYL :

Quarterly/Annual Reports about MYL:

News about MYL:

Articles On GuruFocus.com
Swiss Generics Manufacturer Has Strong 1st Half of Year Aug 22 2016 
10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate? Jul 01 2016 
Growing Generic Drug Market a Good Opportuity for 2 India Firms May 30 2016 
Samuel Isaly Trades in Health Care Stocks in 1st Quarter Apr 27 2016 
John Keeley Comments on Mylan Labs Apr 26 2016 
Ackman to Testify About Valeant Before Senate Apr 26 2016 
Mawer's Investment Newsletter 1st Quarter Apr 15 2016 
Insiders Keep on Selling Facebook and Ford Apr 08 2016 
Buy Perrigo After a Big Selloff? Yes Apr 04 2016 
David Einhorn's Top 5 New Q4 Buys Feb 16 2016 

More From Other Websites
5 Things You Must Know Before the Market Opens Friday Aug 26 2016
Mylan's EpiPen Price Increases Highlight Its Grip on the Market Aug 26 2016
PRESS DIGEST- New York Times business news - Aug 26 Aug 25 2016
[$$] The EpiPen Controversy Isn’t About Mylan Aug 25 2016
Mylan Reacts to EpiPen Backlash Aug 25 2016
Cramer Remix: Dissecting the Fed is a waste of time — it's often wrong Aug 25 2016
Cramer: Mylan's EpiPen represents a big glitch in the system Aug 25 2016
Healthcare sector to remain under pressure: Investor Aug 25 2016
Cramer: Getting to the Heart -- or the Lack of It -- of the EpiPen Issue Aug 25 2016
Cramer Remix: Dissecting the Fed is a waste of time—it’s ... Aug 25 2016
Cramer: Mylan's EpiPen represents a big glitch in the sys... Aug 25 2016
Mylan Boosts Price Assistance for EpiPen Amid Backlash Aug 25 2016
After backlash, EpiPen maker to help reduce patient costs Aug 25 2016
Mylan boosts EpiPen patient programs, doesn't budge on price Aug 25 2016
How Hillary Clinton crushed another rally in biotech Aug 25 2016
Business Highlights Aug 25 2016
Business Highlights Aug 25 2016
Rep. Doggett on drug industry: We need more transparency Aug 25 2016
Mylan Expands Discount Program For EpiPen; PBM Stocks Under Pressure Aug 25 2016
Mylan May Be the First to File Complete ANDA with Paragraph IV Certification for Copaxone 40 Aug 25 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)